Clinical implications of 5 cases of middle east respiratory syndrome coronavirus infection in a South Korean outbreak

Japanese Journal of Infectious Diseases

Volumn 69, Issue 5, 2016, Pages 361-366

  Rhee, Ji Young ^a   Hong, Goohyeon ^b   Ryu, Kyoung Min ^c  

^a Department of Internal Medicine   (South Korea)

^b Division of Allergy and Pulmonary Medicine   (South Korea)

^c Dankook University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; AZITHROMYCIN; C REACTIVE PROTEIN; CEFEPIME; CEFTRIAXONE; LOPINAVIR PLUS RITONAVIR; PARACETAMOL; PIPERACILLIN; RIBAVIRIN; TAZOBACTAM;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CORONAVIRUS INFECTION; CREATININE CLEARANCE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HUMAN; HYPOXEMIA; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; PNEUMONIA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH KOREAN; THORAX RADIOGRAPHY; CASE REPORT; CORONAVIRUS INFECTIONS; EPIDEMIC; ISOLATION AND PURIFICATION; PATHOLOGY; PNEUMONIA, VIRAL; SOUTH KOREA; VIROLOGY;

ADULT; AGED; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PNEUMONIA, VIRAL; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84988040398     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.JJID.2015.445     Document Type: Article

References (8)

1. Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-20.
2. Joint Kingdom of Saudi Arabia/WHO mission. Middle East respiratory syndrome coronavirus. Riyadh, Saudi Arabia, 2013. Available at . Accessed December 12, 2013.
3. Al-Tawfiq JA, Assiri A, Memish ZA. Middle East respiratory syndrome novel corona MERS-CoV infection. Epidemiology and outcome update. Saudi Med J. 2013;34:991-4.
4. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995-1007.
5. Centers for Disease Control and Prevention. First confirmed Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States and updated information on the epidemiology of MERS-CoV infection and guidance for the public, clinicians, and public health authorities-May 2014. MMWR Morb Mortal Wkly Rep. 2014;19:431-6.
6. Momattin H, Mohammed K, Zumla A, et al. Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)-possible lessons from a systematic review of SARS-CoV therapy. Int J Infect Dis. 2013;17:e792-8.
7. Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14: 1090-5.
8. Virlogeux V, Fang VJ, Wu JT, et al. Incubation period duration and severity of clinical disease following severe acute respiratory syndrome coronavirus infection. Epidemiology. 2015;26:666-9.